Benzoylalanine analogues as inhibitors of rat brain kynureninase and kynurenine 3-hydroxylase

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 499-505

  Giordani, A ^a   Corti, L ^a   Cini, M ^a   Marconi, M ^a   Pillan, A ^a   Ferrario, R ^a   Schwarcz, R ^b   Guidetti, P ^b   Speciale, C ^a   Varasi, M ^a  

^a Nerviano Medical Sciences   (Italy)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BENZOIC ACID DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; HYDROLASE; KYNURENINASE; KYNURENINE 3 MONOOXYGENASE; MIXED FUNCTION OXIDASE; NICOTINIC ACID; NICOTINYLALANINE;

ANIMAL; ARTICLE; BRAIN; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; ENZYMOLOGY; KINETICS; RAT; STRUCTURE ACTIVITY RELATION;

ALANINE; ANIMALS; BENZOATES; BRAIN; DRUG DESIGN; ENZYME INHIBITORS; HYDROLASES; KINETICS; KYNURENINE 3-MONOOXYGENASE; MIXED FUNCTION OXYGENASES; NIACIN; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030333846     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_77     Document Type: Article

References (15)

1. Decker R.H., Brown R.R., and Pierce J.M., 1963, Studies on the biological activity of nicotinylalanine, an analogue of kynurenine, J. Biol. Chem. 238: 1049.
2. Dua R.K., Taylor E.W., and Phillips R., 1993, S-aryl-Lcysteine-S,S-dioxides: design and evaluation of a new class of inhibitors of kynureninase, J. Am. Chem. Soc. 115: 1264.
3. Foster A.C., Vezzani A., French E.D., and Schwarcz R., 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48: 273.
4. Kessler K., Terramani T., Lynch G., and Baudry M., 1989, A glycine site associated with N-methyl-D-aspartic acid receptors: characterisation and identification of a new class of antagonists, J. Neurochem. 52: 1319.
5. Meldrum B., 1990, Excitatory amino acid neurotoxicity and neurodegenerative diseases, Trends Neurosci 11: 379.
6. Okuno E., Schmidt W., Parks D.A., Nakamura M., and Schwarcz R., 1991, Measurement of rat brain kynurenine aminotransferase at physiological concentrations, J. Neurochem. 57:533.
7. Pellicciari R., Natalini B., Costantino G., Mahmoud M.R., Mattoli L., Sadeghpour B., Moroni F., Chiarugi A., and Carpenedo R., 1994, Modulation of kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine hydroxylase, J. Med. Chem. 37:647.
8. Phillips R. and Dua R.K., 1991, Stereochemistry and mechanism of aldol reactions catalysed by kynureninase, J. Am. Chem. Soc. 113: 735.
9. Saito K., Nowak T.S., Markey S.P., and Heyes M.P., 1993, Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60: 180.
10. Schwarcz R., Whetsell W.O., and Mangano R.M., 1983, Quinolinic Acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219: 316.
11. Schwarcz R. and Du F., 1991, Quinolinic acid and kynurenic acid in the mammalian brain, in Kynurenine and Serotonin Pathways, R. Schwarcz et al. eds,. Plenum Press, New York, p. 185.
12. Schwarcz R., Du F., Schmidt W., Turski W.A., Gramsbergen J.B., Okuno E., and Roberts R.C., 1992, Kynurenic acid: a potential pathogen in brain disorders, in "Neurotoxins and Neurodegenerative Disease", J.W. Langston and A. Young eds., Ann. N. Y. Acad. Sci. 648:140.
13. Stone T.W., 1993, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev. 45: 309.
14. Takikawa O., Yoshida R., Kido R., and Hayashi O., 1986, Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase, J. Biol. Chem. 261:3648.
15. Varasi M., Della Torre A., Heidempergher F., Pevarello P., Speciale C., Guidetti P., Wells D.R., and Schwarcz R., Derivatives of kynurenine as inhibitors of rat brain kynurenine aminotransferase, Eur. J. Med. Chem., in press.